<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04037384</url>
  </required_header>
  <id_info>
    <org_study_id>UMagdeburg</org_study_id>
    <nct_id>NCT04037384</nct_id>
  </id_info>
  <brief_title>Home Training Possibilities for Glaucoma</brief_title>
  <acronym>EyeTraining</acronym>
  <official_title>Alternative Home Training Possibilities for Glaucoma Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Magdeburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Magdeburg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the trial is to investigate the possibilities of improving visual impairments with
      eye training exercises (eye-yoga) in a total of 30 patients with glaucoma who have not
      previously been treated within a similar training program.

      15 patients will be instructed how to do eye yoga for 4 weeks (max 15 min/day). As a control
      group15 patients will be instructed to read for 15 min/day for 4 weeks.

      The following outcome measures will be investigated: High Resolution Perimetry, Humphrey
      Perimetry, Visual Acuity Test, Contrast Sensitivity Test, Microsaccades measurements,
      Intraocular Pressure Measurement, Electroencephalogram (EEG), Blood Pressure and Pulse
      Measurement and Dynamic Vessel Analysis (DVA - the blood supply in the eye (especially
      vascular dysregulation) .

      Furthermore, factors that could influence response variability and the effectiveness of
      treatment will be analysed: (i) the role of mental stress (or stress resilience) and (ii) the
      influence of personality traits and quality of life.

      The study is intended to further validate this home training program (eye yoga) for the
      treatment of visual impairment in glaucoma.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">August 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual field size determined by perimetry measurements</measure>
    <time_frame>4 weeks</time_frame>
    <description>Changes of the visual field's size, evaluated by static perimetry and high resolution perimetry measurements</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Microsaccade measurements</measure>
    <time_frame>4 weeks</time_frame>
    <description>Changes in the deviation of eye movements when visual targets are followed, using a computerized test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood circulation in the eye</measure>
    <time_frame>4 weeks</time_frame>
    <description>Changes of the diameter of blood vessels in the eye, measured by vessel analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EEG connectivities</measure>
    <time_frame>4 weeks</time_frame>
    <description>Changes in alpha power using EEG recording (128 channels)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Glaucoma</condition>
  <condition>Eye Yoga</condition>
  <arm_group>
    <arm_group_label>Eye Yoga group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Eye yoga exercises</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reading Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Passive reading</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Eye yoga</intervention_name>
    <description>Eye yoga exercises at home given by a trained instructor</description>
    <arm_group_label>Reading Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Passive Reading</intervention_name>
    <description>Passive reading at home</description>
    <arm_group_label>Eye Yoga group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of glaucoma

          -  residual vision

          -  the duration of the disease must be at least 6 months old

          -  the visual field defect must be stable

        Exclusion Criteria:

          -  autoimmune diseases in the acute stage

          -  neurological and mental diseases

          -  diabetic retinopathy

          -  addictions

          -  hypertension (maximum 160/100 mmHg)

          -  retinitis pigmentosa-

          -  pathological nystagmus

          -  non-distant tumors or recurrent tumors

          -  photosensitivity

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Inst. f. Medical Psychology, Univ. of Magdeburg</name>
      <address>
        <city>Magdeburg</city>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Medical Psychology</name>
      <address>
        <city>Magdeburg</city>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Dada T, Mittal D, Mohanty K, Faiq MA, Bhat MA, Yadav RK, Sihota R, Sidhu T, Velpandian T, Kalaivani M, Pandey RM, Gao Y, Sabel BA, Dada R. Mindfulness Meditation Reduces Intraocular Pressure, Lowers Stress Biomarkers and Modulates Gene Expression in Glaucoma: A Randomized Controlled Trial. J Glaucoma. 2018 Dec;27(12):1061-1067. doi: 10.1097/IJG.0000000000001088.</citation>
    <PMID>30256277</PMID>
  </reference>
  <reference>
    <citation>Sabel BA, Flammer J, Merabet LB. Residual vision activation and the brain-eye-vascular triad: Dysregulation, plasticity and restoration in low vision and blindness - a review. Restor Neurol Neurosci. 2018;36(6):767-791. doi: 10.3233/RNN-180880. Review.</citation>
    <PMID>30412515</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>July 3, 2019</study_first_submitted>
  <study_first_submitted_qc>July 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2019</study_first_posted>
  <last_update_submitted>October 2, 2019</last_update_submitted>
  <last_update_submitted_qc>October 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Magdeburg</investigator_affiliation>
    <investigator_full_name>Bernhard A. Sabel</investigator_full_name>
    <investigator_title>Head of Institute, Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The results will be available without restriction</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>After the results are published, unlimited duration</ipd_time_frame>
    <ipd_access_criteria>Contact to the principal investigator</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

